מוצרי מעברות
About
Activities
Investors Relations
Community
Contact
מוצרי מעברות
Activities>
Ta`am Teva Altman

The general partnership Ta'am Teva Altman was formed in 2005 following the merger of two leading companies (Ta'am Teva and Altman), a move that made the new partnership the leading player in the nutritional supplement market in Israel. Maabarot Products holds 68% of the shares of the partnership, and the shareholders of Ta'am Teva (Moshe Toker, company CEO, and Zvi Herschkowitz) hold the remaining 32%.

Ta'am Teva Altman is active in the food supplements and homeopathy category. The company deals in development, branding, sale and distribution, and markets a range of some 1,500 products (food supplements, vitamins and minerals, homeopathy, medical cosmetics, natural and organic foods). Products are marketed and promoted directly to the consumer as well as through the dissemination of medical information among physicians,
dieticians, chemists and other retailers.

Distribution channels include pharmacies, drugstore chains and private chemists, HMOs and nature stores.

Ta'am Teva Altman markets its products under two umbrella brands, Altman and Nutrelife. The major categories in which the company is active and leads the market are arthralgia with the Mega Gluflex brand, Omega 3 with the Alsepa brand, winter products with the Protec brand and more...

Ta'am Teva Altman has approximately 150 employees engaging in sales, the dissemination of medical information and logistics.

General information on the nutritional supplement market in Israel
The VMS market in Israel is estimated at NIS 450 million (with a growth rate of 5%). The growth drivers of the market are increasing awareness and marketing efforts, including the expansion of points of sale and increasing the product offering. In Israel, 34% of the population consumes dietary supplements, compared to 60%-65% in the US and 50% in the UK.

Following the acquisition of Altman and Ta'am Teva, Maabarot holds a significant market share and is a leading player in a relatively fragmented market. Today, the eight largest companies in the industry hold a 50% market share, and the remaining 50% is held by 82 companies.

The Alsepa website: www.alsepa.co.il

Ta`am Teva Altman